KLRS
Kalaris Therapeutics, Inc.
2.90$
-4.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 0.69 | -7.12 | -52.00 | -38.95 | -2.93 | -3.12 | -13.52 | -2.81 | |
| – | 0.01 | 0.06 | 0.41 | – | – | 0.00 | 0.00 | |
| – | – | – | – | 0.08 | 0.03 | 0.18 | 0.13 | |
| 1.20 | 0.49 | -0.88 | 7.09 | 1.02 | -0.24 | -5.05 | 0.22 | |
| 0.00 | 0.12 | 0.20 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | |
| – | -22.84 | -144.94 | 68.13 | – | – | 18.97 | -1.29 | |
| -3.53 | – | – | – | – | – | – | – | |
| – | – | – | – | 1.29 | 1.33 | 3.99 | 0.49 | |
| 8.08 | 42.72 | 249.67 | 0.08 | 3.83 | 3.15 | 0.00 | 10.45 | |
| 8.82 | 12.76 | 52.65 | 28.94 | 0.90 | 0.02 | 5.62 | -1.33 | |
| 0.69 | -7.24 | -52.20 | -38.96 | -2.93 | -3.12 | -13.52 | -2.83 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.